A preclinical study found VitaKine PCT to significantly enhance cardiac function, increasing ejection fraction by 23%, compared to controls. The therapy contains white blood cells in specific ratios and concentrations, offering a precise approach to treating heart attack patients.
A peer-reviewed journal highlights RESPeRATE's effectiveness in treating hypertension, emphasizing the importance of individualized attention and non-traditional methods. Nurse practitioners are encouraged to play a leading role in providing comprehensive care to hypertensive patients.
A new study published in Journal of Human Hypertension demonstrates RESPeRATE's effectiveness in reducing office systolic blood pressure by -10.0 mm Hg in non-insulin dependent diabetics, with a full 88% of patients experiencing significant blood pressure reduction.